Insights

Oncology Value Watchdog Report ASCO 2016: Spotlight on Value

Christina Corridon

Oncology Value Watchdog Report ASCO 2016: Spotlight on Value



> Download

At ASCO 2016, the physician community continued to be highly involved in discussions about value and value initiatives. We identified five key initiatives that are likely to influence the oncology practice going forward. The results of our ASCO physician survey reveal how MDs currently regard and use value frameworks, as well as their perceptions and potential adoption of biosimilars. This report summarizes value initiatives, MD opinions on value, and provides recommendations for manufacturers.


Download These Insights from ZS: Oncology Value Watchdog Report ASCO 2016: Spotlight on Value

About the Expert





Christina Corridon is a Manager in the Boston office and a leader in the ZS Oncology Practice. She has over a decade experience working in the pharmaceutical and biotech industries, with specific expertise in oncology and biosimilars. During her consulting career she has worked on US and global projects spanning commercialization strategy including launch strategy and planning, go-to market strategy, commercial models, marketing strategy and brand planning. Christina has an MPH in Health Policy and Management from the UCLA Fielding School of Public Health and an MBA from the Stern School of Business at New York University focused in Marketing. Christina completed her BA at Cornell University.                 

Contact ZS